RHC.AX ASX
Ramsay Health Care Limited
1W: -1.6%
1M: +5.1%
3M: +26.4%
YTD: +46.6%
1Y: +60.8%
3Y: +14.4%
5Y: -14.9%
A$54.19 ($37.68)
-0.29 (-0.53%)
Weekly Expected Move ±2.2%
A$52
A$53
A$54
A$56
A$57
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$18.6B
+4.4% ▲
5Y CAGR: +7.6%
Gross Profit
$1.8B
-16.2% ▼
5Y CAGR: +2.2%
Operating Income
$1.0B
-52.0% ▼
5Y CAGR: +29.9%
Net Income
$329M
+1271.7% ▲
5Y CAGR: -6.0%
EPS (Diluted)
$1.36
+4494.6% ▲
5Y CAGR: -6.8%
EBITDA
$2.2B
+37.9% ▲
5Y CAGR: +4.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $13.1B | $15.0B | $16.7B | $17.8B | $18.6B |
| YoY Growth | +1.7% | +14.4% | +11.3% | +6.8% | +4.4% |
| Cost of Revenue | $3.1B | $3.3B | $3.7B | $15.7B | $16.8B |
| Gross Profit | $10.0B | $1.3B | $1.6B | $2.1B | $1.8B |
| Gross Margin | 76.2% | 8.5% | 9.7% | 11.9% | 9.5% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $8.3B | $9.4B | $10.3B | $0 | $758M |
| Operating Expenses | $9.7B | $11.0B | $12.0B | $728M | $758M |
| Operating Income | $323M | $660M | $937M | $2.1B | $1.0B |
| Operating Margin | 2.5% | 4.4% | 5.6% | 11.9% | 5.5% |
| Interest Expense | $389M | $514M | $620M | $622M | $608M |
| Income Before Tax | $523M | $527M | $385M | $102M | $514M |
| Tax Expense | $159M | $182M | $121M | $56M | $192M |
| Net Income | $274M | $298M | $889M | $24M | $329M |
| Net Margin | 2.1% | 2.0% | 5.3% | 0.1% | 1.8% |
| EPS (Diluted) | $1.16 | $1.25 | $3.81 | $0.03 | $1.36 |
| EBITDA | $1.6B | $1.8B | $1.8B | $1.6B | $2.2B |
| Shares Outstanding | 228M | 228M | 229M | 230M | 231M |